These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


244 related items for PubMed ID: 16785354

  • 1. Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer.
    Moraca RJ, Low DE.
    Arch Surg; 2006 Jun; 141(6):545-9; discussion 549-51. PubMed ID: 16785354
    [Abstract] [Full Text] [Related]

  • 2. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J, Konda VJ, Ross AS, de Tejada AH, Noffsinger A, Hart J, Lin S, Ferguson MK, Posner MC, Waxman I.
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [Abstract] [Full Text] [Related]

  • 3. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience.
    Wang VS, Hornick JL, Sepulveda JA, Mauer R, Poneros JM.
    Gastrointest Endosc; 2009 Apr; 69(4):777-83. PubMed ID: 19136106
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A, Lightdale CJ, Ross AS, Fedi P, Hart J, Rotterdam H, Noffsinger A, Memeo L, Bhagat G, Waxman I.
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [Abstract] [Full Text] [Related]

  • 5. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J, Ross AS, Konda VJ, Lin S, Noffsinger A, Hart J, Waxman I.
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [Abstract] [Full Text] [Related]

  • 6. Surgical treatment of esophageal high-grade dysplasia.
    Reed MF, Tolis G, Edil BH, Allan JS, Donahue DM, Gaissert HA, Moncure AC, Wain JC, Wright CD, Mathisen DJ.
    Ann Thorac Surg; 2005 Apr; 79(4):1110-5; discussion 1110-5. PubMed ID: 15797034
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated?
    Konda VJ, Ross AS, Ferguson MK, Hart JA, Lin S, Naylor K, Noffsinger A, Posner MC, Dye C, Cislo B, Stearns L, Waxman I.
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):159-64. PubMed ID: 18096439
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia.
    Peyre CG, DeMeester SR, Rizzetto C, Bansal N, Tang AL, Ayazi S, Leers JM, Lipham JC, Hagen JA, DeMeester TR.
    Ann Surg; 2007 Oct; 246(4):665-71; discussion 671-4. PubMed ID: 17893503
    [Abstract] [Full Text] [Related]

  • 11. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD, Buckles D, Al-Kasspooles M.
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [Abstract] [Full Text] [Related]

  • 12. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
    Foroulis CN, Thorpe JA.
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.
    Zehetner J, DeMeester SR.
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671
    [Abstract] [Full Text] [Related]

  • 14. Predictors of postoperative quality of life after esophagectomy for cancer.
    Djärv T, Blazeby JM, Lagergren P.
    J Clin Oncol; 2009 Apr 20; 27(12):1963-8. PubMed ID: 19289614
    [Abstract] [Full Text] [Related]

  • 15. Outcomes of dysplasia arising in Barrett's esophagus: a dynamic view.
    Romagnoli R, Collard JM, Gutschow C, Yamusah N, Salizzoni M.
    J Am Coll Surg; 2003 Sep 20; 197(3):365-71. PubMed ID: 12946790
    [Abstract] [Full Text] [Related]

  • 16. Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis.
    Pohl H, Sonnenberg A, Strobel S, Eckardt A, Rösch T.
    Gastrointest Endosc; 2009 Oct 20; 70(4):623-31. PubMed ID: 19394011
    [Abstract] [Full Text] [Related]

  • 17. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma.
    Zehetner J, DeMeester SR, Hagen JA, Ayazi S, Augustin F, Lipham JC, DeMeester TR.
    J Thorac Cardiovasc Surg; 2011 Jan 20; 141(1):39-47. PubMed ID: 21055772
    [Abstract] [Full Text] [Related]

  • 18. Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia.
    Nguyen NT, Schauer P, Luketich JD.
    Surgery; 2000 Mar 20; 127(3):284-90. PubMed ID: 10715983
    [Abstract] [Full Text] [Related]

  • 19. Does cancer risk affect health-related quality of life in patients with Barrett's esophagus?
    Gerson LB, Ullah N, Hastie T, Goldstein MK.
    Gastrointest Endosc; 2007 Jan 20; 65(1):16-25. PubMed ID: 17185075
    [Abstract] [Full Text] [Related]

  • 20. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V, Schlup M, Lübcke R, Livingstone V, Schultz M.
    J Gastroenterol Hepatol; 2008 Sep 20; 23(9):1362-7. PubMed ID: 18205769
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.